Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 1, 2012, Pages 493-498

  Haeberle, Beate ^a   Von Schweinitz, Dietrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Childhood liver tumor; Cisplatin; HB 89; HB94; Hepatoblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ARTICLE; BONE MARROW DEPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG MEGADOSE; GERMANY; HEPATOBLASTOMA; HUMAN; LAPAROTOMY; LIVER BIOPSY; LIVER RESECTION; LIVER TRANSPLANTATION; LUNG METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; CHILD; CLINICAL TRIAL (TOPIC); LIVER TUMOR; REVIEW;

CHILD; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; GERMANY; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS;

EID: 84860861878     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e395     Document Type: Article

References (24)

1. P. Kaatsch, C. Spix: Jahresbericht Annual Report 2006/07, German Childhood Cancer Registry P. Kaatsch, Ed., Deutsches Kinderkrebsregister am Institut fuer Medizinische Biometrie, Epidemiologie und Informatik (IMBEI) Universitaetsklinikum Mainz, 47 -56 (2008).
2. H. Mildenberger, D. Burger, P. Weinel: Hepatoblastoma: a retrospective study and proposal of a treatment protocol. Z Kinderchir 44, 78-82 (1989)
3. J. Quinn, A. J. Altman, H. T. Robinson, R. W. Cooke, D. W. Hight, J. H. Foster: Adriamycin and cisplatin for hepatoblastoma. Cancer 56, 1926-9 (1985)
4. D. von Schweinitz, D. Burger, U. Bode, P. Weinel, R. Erttmann, H. Hecker, H. Mildenberger: Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol. Klin Padiatr 206, 282-8 (1994)
5. D. von Schweinitz, D. J. Byrd, H. Hecker, P. Weinel, U. Bode, D. Burger, R. Erttmann, D. Harms, H. Mildenberger: Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. Eur J Cancer 33, 1243-9 (1997)
6. D. von Schweinitz, D. Burger, H. Mildenberger: Is laparatomy the first step in treatment of childhood liver tumors?-The experience from the German Cooperative Pediatric Liver Tumor Study HB-89. Eur J Pediatr Surg 4, 82-6 (1994)
7. J. Fuchs, J. Rydzynski, D. Von Schweinitz, U. Bode, H. Hecker, P. Weinel, D. Burger, D. Harms, R. Erttmann, K. Oldhafer, H. Mildenberger: Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 95, 172-82 (2002)
8. B. Haeberle, U. Bode, D. von Schweinitz: Differentiated treatment protocols for high- and standard-risk hepatoblastoma - an interim report of the German liver tumor study HB99. Klin Padiatr 215,159-165 (2003)
9. B. Haeberle, I. Schmid, D. von Schweinitz: Is there a very high risk group in childhood hepatoblastoma? A subgroup analysis of the GPOH study HB99 (Abstract). Pediatr Blood Cancer 55, 815 (2010)
10. D. Roebuck, J., D. Aronson, P. Clapuyt, P. Czauderna, J. de Ville de Goyet, F. Gauthier, G. Mackinlay, R. Maibach, K. McHugh, O. E. Olsen, J. B. Otte, D. Pariente, J. Plaschkes, M. Childs, G. Perilongo: 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 37, 123-32; quiz 249-50 (2007)
11. D. C. Aronson, J. M. Schnater, C. R. Staalman, G. J. Weverling, J. Plaschkes, G. Perilongo, J. Brown, A. Phillips, J. B. Otte, P. Czauderna, G. MacKinlay, A. Vos: Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 23, 1245-52 (2005)
12. D. von Schweinitz, H. Hecker, D. Harms, U. Bode, P. Weinel, D. Burger, R. Erttmann, H. Mildenberger: Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma-a report from the German Cooperative Pediatric Liver Tumor Study HB-89. J Pediatr Surg 30, 845-52 (1995)
13. J. Brown, G. Perilongo, E. Shafford, J. Keeling, J. Pritchard, P. Brock, C. Dicks-Mireaux, A. Phillips, A. Vos, J. Plaschkes: Pretreatment prognostic factors for children with hepatoblastoma - results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36, 1418-25 (2000)
14. G. Perilongo, E. Shafford, R. Maibach, D. Aronson, L. Brugieres, P. Brock, M. Childs, P. Czauderna, G. MacKinlay, J. B. Otte, J. Pritchard, R. Rondelli, M. Scopinaro, C. Staalman, J. Plaschkes: Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2. Eur J Cancer 40, 411-21 (2004)
15. G. Perilongo, R. Maibach, E. Shafford, L. Brugieres, P. Brock, B. Morland, B. de Camargo, J. Zsiros, D. Roebuck, A. Zimmermann, D. Aronson, M. Childs, E. Widing, V. Laithier, J. Plaschkes, J. Pritchard, M. Scopinaro, G. MacKinlay, P. Czauderna: Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 361, 1662-70 (2009)
16. S. W. Warmann, J. Fuchs: Drug resistance in hepatoblastoma. Curr Pharm Biotechnol 8, 93-7 (2007)
17. T. Oue, A. Yoneda, S. Uehara, H. Yamanaka, M. Fukuzawa: Increased expression of multidrug resistanceassociated genes after chemotherapy in pediatric solid malignancies. Journal of Pediatric Surgery 44, 377-380 (2009)
18. S. Warmann, G. Gohring, B. Teichmann, H. Geerlings, T. Pietsch, J. Fuchs: P-glycoprotein modulation improves in vitro chemosensitivity in malignant pediatric liver tumors. Anticancer Res 23, 4607-11 (2003)
19. R. L. Meyers, H. M. Katzenstein, M. Krailo, E. D. McGahren, M. H. Malogolowkin: Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. J Pediatr Surg 42, 2050-6 (2007)
20. B. Haeberle, J. Fuchs, I. Schmid, U. Bode, D. von Schweinitz: Infiltration of large vesseks in high-risk hepatoblastoma - is resectablity and complete remission achievable? (Abstract). Pediatr Blood Cancer 53, 716 (2009)
21. J. Zsiros, M. R. Brugieres Successful treatment of high risk hepatoblastoma - final report of the SIOPEL 3 trial of the International Childhood Liver Tumours Strategy Group (Abstract). Pediatr Blood Cancer 4, 420 (2007)
22. S. Emre, G. J. McKenna: Liver tumors in children. Pediatr Transplant 8, 632-8 (2004)
23. J. B. Otte, J. Pritchard, D. C. Aronson, J. Brown, P. Czauderna, R. Maibach, G. Perilongo, E. Shafford, J. Plaschkes: Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 42, 74-83 (2004)
24. J. B. Otte, J. de Ville de Goyet, R. Reding: Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatr Transplant 9, 557-65 (2005)